US Capitol Capsule: Obama superbug attack plan hinges on funding, cooperation
This article was originally published in Scrip
President Barack Obama on 27 March unveiled an aggressive five-year plan to combat the growing scourge of superbugs, which infect about 2 million Americans each year, killing 23,000.
You may also be interested in...
The biotech startups that will be supported by a new transatlantic public-private partnership could end up with innovative products enticing enough to get some large biopharmaceutical firms back into the antibiotic game.
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.